Review of Article: Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. Eikelboom JW, Connolly SJ, Bosch J, et al. for the COMPASS Investigators
Cardiovascular disease accounts for nearly 801,000 deaths in the United States.1 Patients with vascular disease have a 20%-60% increased risk of a myocardial infarction (MI), a 40% increased risk of a stroke, and a 2- to 6-fold increase of death due to cardiovascular disease.2,3 The primary goal in antiplatelet therapy is to reduce the risk of MI, stroke, o r vascular death in patients with atherosclerosis and has been the cornerstone in medical management of the patient with cardiovascular disease.
Source: Journal of Vascular Nursing - Category: Nursing Authors: Debra Kohlman-Trigoboff Tags: Research Column Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Heart | Heart Attack | Nurses | Nursing | Stroke | USA Health